* Your assessment is very important for improving the workof artificial intelligence, which forms the content of this project
Download Roach: Introductory Clinical Pharmacology
Survey
Document related concepts
Transcript
Introduction to Clinical Pharmacology Chapter 51Immunostimulant Drugs Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Types and Functions of Blood Cells • Red blood cells (erythrocytes)-supply oxygen • White blood cells (leukocytes)-protect against microorganisms • Platelets (megakaryocytes)-control bleeding • Kidney disease can cause hematologic failure – *anemia, bleeding and infection may result Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treatment of Anemia, Bleeding and Prevention of Infection • Colony-stimulating drugs • Oprelvekin • Erythropoiesis-stimulating agents – Glycoproteins that stimulate and regulate the production of erythrocytes • Iron • Folic Acid • Vitamin B12 Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs used to Stimulate White Blood Cells: Actions and Uses • Colony stimulating factors (CSF) glycoproteins act on hematopoetic cells to stimulate proliferation, differentiation, and maturation of white blood cells – *Used in chemotherapy-induced neutropenia • Filgastim-used after a cycle of chemotherapy • Pegfilgastim-used as single dose between chemotherapy cycle • Sargramostim-used following BMT, induction chemotherapy used with leukemia, and to stimulate stem cells for harvest. Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs used to Stimulate White Blood Cells: Adverse Reactions • Bone pain • Hypertension • Nausea and vomitting • Alopecia • Hypersensitivity or allergic reactions Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs used to Stimulate White Blood Cells: Contraindications, Precautions and Interactions • Contraindicated in patients with hypersensitivity • Pregnancy category (C), caution when breast feeding • Filgrastim-caution with hyporthyroid disease • Pegfilgrastim-cause sickle cell crisis • Can stimulate cancer cell growth • Increased netrophil when used with Lithium Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs used to Stimulate Blood Platelets: Actions and Uses • Oprelvekin-acts to stimulate thrombopoiesis -reduces need for multiple platelet transfusion -used to treat or prevent thrombocytopenia associated with chemotherapy for solid tumor cancer treatments Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs used to Stimulate Blood Platelets: Adverse Reactions • General reactions: -fluid retention, peripheral edema, dyspnea, syncope, fever, allergic reaction • Cardiovascular reactions: -tachycardia, palpitations, atrial fibrillation, arrhythmias resulting in stroke and pulmonary edema, capillary leak syndrome Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs used to Stimulate Blood Platelets: Contraindications, Precautions and Interactions • Contraindicated to patient hypersensitivity and not used with chemotherapy that is extremely myelosuppressive. • Use cautiously in patients with renal, heart failure or atrial arrhythmias • Low potassium (hypokalemia) can occur with cancer chemotherapy agent, ifosfamide • Pregnancy category (C) and stop breast feeding • Anaphylactic-type reactions discontinue use Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Anemia Associated With Chronic Illness: Actions and Uses • Epoetin alfa: Drug that stimulates erythropoiesis – Used to treat anemia associated with: Chronic renal failure; chemotherapy for cancer treatment; zidovudine therapy for human immunodeficiency virus; postsurgical blood replacement in place of allogeneic transfusions • Darbepoetin alfa an erythropoiesis-stimulating protein: Used to treat anemia Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Anemia Associated With Chronic Illness: Adverse Reactions • Adverse reactions: – Hypertension; headache; nausea; vomiting; diarrhea; rashes; fatigue; arthralgia; skin reaction at injection site Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Anemia Associated With Chronic Illness: Contraindications and Precautions • Epoetin alfa: Contraindicated in patients with uncontrolled hypertension; those needing emergency transfusion; those with hypersensitivity to human albumin • Darbepoetin alfa: Contraindicated in patients with uncontrolled hypertension, those allergic to drug • Epoetin alfa darbepoetin alfa: Used with caution in patients with hypertension; heart disease; congestive heart failure; history of seizures Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Iron Deficiency Anemia: Actions and Uses • Iron preparations: – Act by elevating serum iron concentration, which replenishes hemoglobin and depleted iron stores • Parenteral iron: – Used when patient cannot take oral drugs or when patient experiences gastrointestinal intolerance to oral iron administration; treating iron deficiency anemia Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Iron Deficiency Anemia: Adverse Reactions, Contraindications • Adverse reactions: Gastrointestinal reactions: GI irritation, vomiting, constipation, diarrhea, darker stools; Generalized system reactions-fatigue with Feosol/ferrous sulfate • Iron supplements: Contraindicated in patients with known hypersensitivity to drug, or any component of the drug Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Iron Deficiency Anemia: Contraindications, and Precautions • Iron compounds – Contraindicated in patients with hemochromatosis or hemolytic anemia – Used cautiously in patients with hypersensitivity to aspirin Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Iron Deficiency Anemia: Interactions Interactant Drug Effect of Interaction Antibiotics Decreased GI absorption of the antibiotic Levothyroxine Decreased absorption of levothyroxine Levodopa, methyldopa Decreased effect of Parkinson’s medication Ascorbic acid (vitamin C) Increased absorption of iron Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Folic Acid Deficiency Anemia: Action and Uses • Folic acid: Used in treating megaloblastic anemia; for women of childbearing age to decrease incidence of neural tube defects • Leucovorin: Used to diminish hematologic effects of methotrexate – Used in treating certain types of cancer Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Folic Acid Deficiency Anemia: Contraindications and Precautions and Interactions • Folic acid, leucovorin: Contraindicated for treating pernicious anemia, other anemias in which vitamin B12 is deficient • Used cautiously within RDA guidelines • Pregnant women: With folate deficiency are at increased risk for complications of pregnancy, fetal abnormalities • Signs of folate deficiency: Occur when sulfasalazine administered concurrently • Increase in seizure activity: Occur when folic acid is administered with hydantoins Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Vitamin B12 Deficiency Anemia: Actions, Uses, Adverse Reactions • Vitamin B12 used to treat patients with a vitamin B12 deficiency; also used to perform the Schilling test • Adverse reactions: Mild diarrhea, itching; increase in RBC production; acne; peripheral vascular thrombosis; congestive heart failure; pulmonary edema Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Drugs Used in Treating Vitamin B12 Deficiency Anemia: Contraindications, Precautions, and Interactions • Contraindicated in patients allergic to cyanocobalamin • Administered cautiously during pregnancy, in patients with pulmonary disease, anemia • Alcohol, neomycin, colchicine decrease the absorption of oral vitamin B12 Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Assessment • Preadministration assessment: – Obtain general health history, asks about symptoms of anemia – Take vital signs to provide baseline during therapy – Physical assessments: patient’s general appearance and, in severely anemic patient, evaluation of patient’s ability to carry out activities of daily living Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Assessment • Ongoing Assessment: – Monitor patient for adverse reactions; reports any occurrence of adverse reactions to primary health care provider before next dose is due – Inform patient that color of stool will become darker or black – Assess the patient for relief of symptoms of anemia Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Diagnoses • Fatigue- related to dilutional anemia caused by fluid retention • Imbalanced Nutrition: Less Than Body Requirements- related to lack of iron, folic acid, other (specify) in the diet • Constipation- related to adverse reaction to iron therapy Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Planning • The expected outcome include: – Optimal response to therapy: – Supporting the patient needs related to the management of adverse reactions – Understanding of and compliance with prescribed treatment regimen Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation • Promoting an optimal response to therapy: – Iron: Check with hospital pharmacist regarding simultaneous administration of iron salts with other drugs; monitor: patient for allergic response for at least 1 hour after test dose and before administering remaining dose – Vitamin B12: patients with vitamin B12 anemia are treated with vitamin administered by parenteral route weekly Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation • Promoting an optimal response to therapy (cont’d): – Epoetin alfa: Monitor blood pressure closely; report any rise of 20 mm Hg or more in systolic; diastolic pressure to primary health care provider – Monitor Hct** Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation • Monitoring and managing patient needs: – Altered nutrition: Recommend: Balanced diet with emphasis on foods that are high in iron, folic acid (collards, greens, salmon, chicken, wheat bread) – Constipation: Instruct patient to increase fluid intake to 10 to 12 glasses of water daily, eat a diet high in fiber, and increase activity Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation • Educating the patient and family: – Explain medical regimen thoroughly to patient and family •Emphasize importance of following the prescribed treatment regimen – Iron: •Take this drug with water on empty stomach, if gastrointestinal upset occurs, take drug with food or meals Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation • Educating the patient and family: – Iron (cont’d): •This drug causes darkening of stools, constipation, or diarrhea; if constipation or diarrhea becomes severe, contact primary health care provider •Iron deficiency occurs: Cause must be determined and therapy should be under the care of a health care provider Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation • Educating the patient and family (cont’d): – Epoetin alfa: •Strict compliance with antihypertensive drug regimen: Important in patients with known hypertension during epoetin alfa therapy •Adverse reactions: Dizziness; headache; fatigue; joint pain; nausea; vomiting; diarrhea -Report adverse reactions Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation • Educating the patient and family (cont’d): – Leucovorin: •Megaloblastic anemia: Adhere to diet prescribed by the primary health care provider •If purchase of foods high in protein becomes a problem, discuss this with primary health care provider Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Implementation • Educating the patient and family (cont’d): – Vitamin B12: •Nutritional deficiency of vitamin B12: Eat a balanced diet that includes seafood, eggs, meats, and dairy products •Pernicious anemia: Lifetime therapy is necessary, avoid contact with infections, report any signs of infection to primary health care provider immediately Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins Nursing Process: Evaluation • Therapeutic effect of the drug is achieved • Patient has normal bowel movements • An adequate nutritional intake is achieved • Patient and family demonstrate an understanding of the drug regimen • Patient verbalizes the importance of complying with the prescribed treatment regimen Copyright © 2010 Wolters Kluwer Health | Lippincott Williams & Wilkins